APYX MEDICAL CORPORATION (APYX) Gross margin 2016–2025
APYX MEDICAL CORPORATION (APYX) gross margin by fiscal year — reported gross profit divided by reported revenue.
62.5%FY2025 · since FY2016: 58.0% → 62.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 62.5% | +1.5 pp |
| FY2024 | 61.0% | -3.5 pp |
| FY2023 | 64.5% | -1.0 pp |
| FY2022 | 65.4% | -3.8 pp |
| FY2021 | 69.3% | +6.1 pp |
| FY2020 | 63.2% | -4.5 pp |
| FY2019 | 67.6% | +2.4 pp |
| FY2018 | 65.2% | -2.8 pp |
| FY2017 | 68.0% | +10.0 pp |
| FY2016 | 58.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice